0.00Open0.17Pre Close0 Volume0 Open Interest89.00Strike Price0.00Turnover89.22%IV10.65%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.17Extrinsic Value100Contract SizeAmericanOptions Type0.0730Delta0.0259Gamma474.03Leverage Ratio-0.1435Theta0.0003Rho34.63Eff Leverage0.0083Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet